帕金森病的并发病理的流行:对预后,诊断和对常见病原性机制的见解的影响
Lauren Walker1, Johannes Attems1
1Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.
Journal of Parkinson's disease
|December 25, 2023
概括
帕金森病 (PD) 通常涉及诸如阿尔茨海默病,心血管疾病和TDP-43脑病变等同时存在的病理. 了解这些复杂的相互作用是开发更好的PD诊断和治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 老年医学 老年医学
背景情况:
- 帕金森病 (PD) 经常伴随着同时存在的病理,包括阿尔茨海默病 (高酸化,粉样β斑块),心血管疾病和边缘主导的TDP-43脑病变 (LATE),以及勒维体病理 (α-synuclein).
- 新出现的证据表明,这些病理之间存在协同作用,可能加速认知衰退,并改变PD患者的典型疾病进展.
研究的目的:
- 审查在帕金森病中同时发现的常见病理的患病率和相互关系.
- 确定共享的遗传风险因素和新兴生物标志物,以改善PD与共存病理的诊断.
主要方法:
- 文献综述和现有关于PD同时发生的病理学研究的综合.
- 对复杂的PD病例的遗传风险因素和生物标志物开发的分析.
主要成果:
- 在帕金森病中,多种神经病理经常同时存在,影响疾病的发展轨迹.
- 为了提高诊断精度,正在研究共享的遗传因素和新的生物标志物.
结论:
- 帕金森病的异质性很可能是由遗传,环境和病理因素之间的复杂相互作用驱动的.
- 对这些多因素关系的进一步研究对于提高诊断准确性和开发帕金森病疾病修饰疗法至关重要.
相关概念视频
Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
673
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
673
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492


